BMJ Medicine · Published 2026-07-01 · DOI 10.1136/bmjmed-2025-002307
Maximilian Siebert, Rylee McGonigle, Alba Gutiérrez-Sacristán, Huseyin Naci, Anita K. Wagner, Florence T Bourgeois
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Siebert, M., McGonigle, R., Gutiérrez-Sacristán, A., et al. (2026). Completion and outcomes of postmarketing requirements and commitments issued by the US Food and Drug Administration for new drugs, 2016-24: cross sectional evaluation of postmarketing studies. BMJ Medicine. https://doi.org/10.1136/bmjmed-2025-002307